Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer
Clinical trial NCT04304209 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04304209
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-28
- Primary completion
- 2026-10-18
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.